# Sid Sijbrandij

En popüler podcast bölümleri
Güncellenmiş:

What's New in Science With Sabine and Lawrence | Ghost Murmers, New Wires, Cosmic Questions, And AI cures?

I’m back with my friend and colleague Sabine Hossenfelder for another episode of “What’s New in Science”. Spending time with Sabine was a nice chance to step away from my physics lecture series for a bit. I know many of you have been enjoying the lectures, so don’t worry, they’ll be back soon. In…

Google Don’t Front | TechSNAP 376

Google and Amazon recently shutdown Domain Fronting. Their abrupt change has created a building backlash. We’ll explain what Domain Fronting is, how activists can use it to avoid censorship, and why large organizations are compelled to disable it. Plus how road navigation systems can be spoofe…

Crosswire — March 31, 2026

Geopolitics The conflict involving the US, Israel, and Iran continues to escalate with significant geopolitical ramifications. Egypt is taking measures to mitigate the impact of soaring energy prices due to the Iran war, as the blockade of the Strait of Hormuz disrupts oil supplies. The US is consi…

A New Operating System for Cancer: How Sid Sijbrandij is Outpacing an Evolving Disease

A New Operating System for Cancer: How Sid Sijbrandij Is Outpacing an Evolving Disease Going “Founder Mode” — And What Patients Can Do to Take Control of Their Own Care What do you do when you’re told:“There’s nothing more we can do”? That’s the moment Sid Sijbrandij faced after completing standar…

How GLP-1s are paving the way for the new era of biotech - Elliot Hershberg, Investor & Blogger

Elliot Hershberg is a partner at Amplify Partners and author of the popular blog Century of Biology. In this episode, we talk about GLP-1s as a breakthrough moment for biotech, why drug development is starting to behave like software, and how falling discovery costs could finally free biotech start…

185 - Medicine Without Permission | Niklas Anzinger

Self-Sovereign Medicine: Biotech, Right to Try, and the Cracks in the FDA's Monopoly – Niklas Anzinger is a German entrepreneur who has probably done more than any single person to put Próspera on the longevity biotech map. He is the founder and General Partner of Infinita VC, the first VC fund ba…

Maximal Cancer Diagnostics with Sid Sijbrandij and Jacob Stern

In 2024, Sid Sijbrandij got the news that no cancer patient wants to hear: his tumor was back and his doctors told him they had nothing left to offer.  Sid, a tech entrepreneur who up until that point had been running his company, GitLab, went all in, doing as much testing and as many treatments a…

How to design a cancer vaccine (and vastly improve them): Alex Rubinsteyn & Ben Vincent

Spotify: https://open.spotify.com/episode/5xk4OjH1jVYbDR6xTTvqCY?si=11564348b75a459a Apple Podcasts: https://podcasts.apple.com/us/podcast/owl-posting/id1758545538?i=1000775598448 Youtube: https://youtu.be/EmbciAO9d-M Transcript: https://www.owlposting.com/p/how-to-design-a-cancer-vaccine-and?open=…

Hope You Like Burning Man Sculptures with Max Blue

Max Blue is one of San Francisco's few remaining art critics in legacy media (see: his column in SF Examiner); he also contributes regularly to Hyperallergic. Max gives the best brief introduction of the big art movements San Francisco is most well known for, and names names including: BXP,…

AI, Cancer Vaccines, and the Future of Personalized Medicine | Sid Sijbrandij on GitLab + Biotech

Can AI help design personalized cancer vaccines? Visit Future of Cancer Care Today: https://sijbrandijfoundation.org/fcct In this episode, we speak with Sid Sijbrandij, founder of GitLab who went "Founder Mode" against his own cancer. Sid discusses personalized cancer vaccines, tumor sequencing, im…